Search

Author/Creator Takiguchi, Y.

1. 3064 NEJ016: Phase II study of carboplatin and weekly paclitaxel plus bevacizumab followed by bevacizumab for highly selected elderly non-squamous non-small cell lung cancer patients. (September 2015)

Authors:
Harada, T.; Miura, S.; Maemondo, M.; Iwashima, A.; Sugawara, S.; Kobayashi, K.; Inoue, A.; Nakagawa, T.; Takiguchi, Y.; Watanabe, H.; Seike, M.; Ishida, T.; Terada, M.; Gemma, A.; Yoshizawa, H.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S617
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 3072 Phase 2: Docetaxel with or without ramucirumab as therapy for non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutations after prior EGFR tyrosine kinase inhibitor (TKI) and platinum-based chemotherapy. (September 2015)

Authors:
Kasahara, K.; Kiura, K.; Nogami, N.; Takayama, K.; Takiguchi, Y.; Hirashima, T.; Aoe, K.; Hayashi, H.; Saka, H.; Takahashi, K.; Imamura, F.; Oizumi, S.; Inoue, A.; Satouchi, M.; Tatsumi, M.; Nakamura, T.; Enatsu, S.; Tamura, T.; Nakagawa, K.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S620
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search